ArticleClinical and experimental hepatology2025
Oral health-related quality of life and oral function in patients with metabolic dysfunction associated steatotic liver disease.
Article in Clinical and experimental hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim of the study: Patients with metabolic dysfunction associated steatotic liver disease (MASLD) frequently experience periodontal diseases, but little is known about oral health-related quality of life (OHRQoL). Additionally, oral functions and the association between oral functions and MASLD remain unknown. Material and methods: The study included 19 MASLD patients and 26 control subjects. OHRQoL was assessed using the General Oral Health Assessment Index (GOHAI). Additionally, oral hygiene, periodontal conditions, and oral functions, including numbers of functional and dysfunctional teeth, were examined. Results: All MASLD patients were in the early stage of liver fibrosis and reported lower OHRQoL, particularly in physical components, including biting and chewing, and fluent speech. However, objective examinations revealed no significant differences in chewing and tongue pressure between MASLD and control subjects. Oral diadochokinesis also showed no significant difference. In contrast, MASLD patients exhibited fewer functional teeth, poorer oral hygiene, and more deteriorated periodontal condition. A reduced number of teeth was associated with MASLD, independent of periodontitis. Conclusions: MASLD patients reported lower OHRQoL and perceived impaired oral functions before actual functional loss occurred. A decreased number of functional teeth was associated with the presence of MASLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.